Viatris, Inc. is a global healthcare company, which engages in the provision of healthcare and pharmaceutical products. The company is headquartered in Canonsburg, Pennsylvania. The firm's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment reflects its operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America, and the Middle East, as well as the Company’s Antiretroviral medicines (ARV) franchise. Its pipeline and research and development capabilities include expertise in formulation, device development, toxicology, analytical, clinical, bioanalytical, medical affairs, product safety and risk management across a range of therapeutic areas. The company produces oral solid doses, injectables, and products with complex dosage forms.
Mr. Scott Smith 2022 'den beri şirketle birlikte olan Viatris Inc 'in Chief Executive Officer 'ıdır.
VTRS hissesinin fiyat performansı nasıl?
VTRS 'in mevcut fiyatı $13 'dir, son işlem günde 0.34% azalmış etti.
Viatris Inc için ana iş temaları veya sektörler nelerdir?
Viatris Inc Pharmaceuticals endüstrisine ait ve sektör Health Care 'dir
Viatris Inc 'in piyasa değerlemesi nedir?
Viatris Inc 'in mevcut piyasa değerlemesi $14.9B 'dir
Viatris Inc al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 11 analist Viatris Inc için analist derecelendirmeleri gerçekleştirdi, bunlar 3 güçlü al, 5 al, 6 tut, 2 sat ve 3 güçlü sat içermektedir